Biotech by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Biogen has the lowest figure of the 19 biotech ranked by P/S ratio, at 3.8, followed by Qiagen (4.9) and Neurocrine Biosciences (5.8). Figures as of 18 Nov 2026, 15:06 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
Lowest
Biogen3.8
Median
14.6
Combined market value
NOK 8.23T
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

Biotech by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care3.8NOK 359.6BNOK 2,432.78 0.08% up 49% up United States
2QiagenQGEN · Health Care4.9NOK 99.5BNOK 481.76 0.09% down 12% up Netherlands
3Neurocrine BiosciencesNBIX · Health Care5.8NOK 160.9BNOK 1,589.64 1.15% down 20% up United States
4BioNTechBNTX · Health Care6.6NOK 204.2BNOK 823.56 0.13% up 16% down Germany
5AmgenAMGN · Health Care6.7NOK 2.37TNOK 4,385.59 1.19% down 34% up United States
6Gilead SciencesGILD · Health Care7.2NOK 2.04TNOK 1,645.66 0.28% down 33% up United States
7ExelixisEXEL · Health Care7.3NOK 163.7BNOK 670.81 1.04% up 63% up United States
8Halozyme TherapeuticsHALO · Health Care7.9NOK 107.4BNOK 941.81 1.25% up 37% up United States
9Bio-TechneTECH · Health Care9.4NOK 110.7BNOK 704.92 0.14% up 26% up United States
10argenxARGX · Health Care14.6NOK 587BNOK 9,334.02 1.64% up 4% up Belgium
11RepligenRGEN · Health Care15.0NOK 107.3BNOK 1,678.23 6.76% up 5% up United States
12Adaptive BiotechnologiesADPT · Health Care17.0NOK 45.5BNOK 281.37 1.90% up 88% up United States
13Twist BioscienceTWST · Health Care21.4NOK 78.2BNOK 1,146.51 5.62% up 340% up United States
14Krystal BiotechKRYS · Health Care23.5NOK 88.8BNOK 2,995.71 3.53% up 46% up United States
15ModernaMRNA · Health Care43.2NOK 814BNOK 2,011.79 0.37% up 755% up United States
16ImmunityBioIBRX · Health Care61.4NOK 67.4BNOK 63.34 4.39% up 193% up United States
17Kymera TherapeuticsKYMR · Health Care269NOK 102.3BNOK 1,198.41 1.75% up 87% up United States
18CRISPR TherapeuticsCRSP · Health Care1164NOK 39.6BNOK 408.24 4.91% up 21% down Switzerland
19CG OncologyCGON · Health Care1712NOK 67BNOK 750.62 1.89% down 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6923 NOK). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech have the lowest P/S ratio?

Biogen (3.8), Qiagen (4.9) and Neurocrine Biosciences (5.8) have the lowest P/S ratio of the 19 biotech ranked here as of 18 Nov 2026, 15:06 UTC.

How many biotech are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 19 biotech ranked by P/S ratio have a combined market value of NOK 8.23T as of 18 Nov 2026, 15:06 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.